# Autologous Stem/Stromal Cellular Stromal Vascular Fraction (cSVF) In Frailty-Aging Processes

> **NCT03514537** · NA · SUSPENDED · sponsor: **Healeon Medical Inc** · enrollment: 200 (estimated)

## Conditions studied

- Frail Elderly Syndrome
- Aging
- Degenerative Disease

## Interventions

- **PROCEDURE:** Microcannula harvest adipose stromal tissues
- **DEVICE:** Centricyte 1000
- **PROCEDURE:** Sterile Normal Saline IV Deployment of cSVF
- **DRUG:** Liberase
- **DRUG:** Saline Solution

## Key facts

- **NCT ID:** NCT03514537
- **Lead sponsor:** Healeon Medical Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2018-03-15
- **Primary completion:** 2027-03-15
- **Final completion:** 2028-01-15
- **Target enrollment:** 200 (ESTIMATED)
- **Why stopped:** COVID -19 closed facility and testing of subjects
- **Last updated:** 2025-09-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03514537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03514537, "Autologous Stem/Stromal Cellular Stromal Vascular Fraction (cSVF) In Frailty-Aging Processes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03514537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*